Article
HPV-positive Oropharyngeal Cancer: Prevention To Precision Treatment
Human papillomavirus vaccination has dramatically reduced cervical cancer rates in young women across the EU, but could the same approach work for HPV-positive oropharyngeal cancer, which has tripled in incidence among Scandinavian men over three decades? As gender-neutral vaccination programs roll out and immunotherapy strategies evolve, the landscape for treating and potentially preventing HPV-driven head and neck cancers is undergoing a fundamental transformation.
Potter Clarkson